Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).

Marcellin, Fabienne; Mourad, Abbas; Lemoine, Maud; Kouanfack, Charles; Seydi, Moussa; Carrieri, Patrizia; Attia, Alain; Protopopescu, Camelia; Lacombe, Karine; Boyer, Sylvie

Marcellin, Fabienne; Mourad, Abbas; Lemoine, Maud; Kouanfack, Charles; Seydi, Moussa; Carrieri, Patrizia; Attia, Alain; Protopopescu, Camelia; Lacombe, Karine; Boyer, Sylvie.

Afiliação

Marcellin F; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Mourad A; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Lemoine M; Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology and Gastroenterology, St Mary's Hospital, Imperial College, London, UK.
Kouanfack C; Hôpital de Jour, Hôpital Central de Yaoundé, Cameroon.
Seydi M; Faculté de Médecine et des Sciences Pharmaceutiques, Université de Dschang, Dschang, Cameroon.
Carrieri P; Service des Maladies Infectieuses et Tropicales, CHU Fann, Dakar, Senegal.
Attia A; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Protopopescu C; Service d'hépatologie, CHU Yopougon, Abidjan, Cote d'Ivoire.
Lacombe K; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
Boyer S; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Paris, France.

JHEP Rep ; 5(3): 100665, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36686592

Palavras-chave

DAA, direct-acting antiviral; EOT, end-of-treatment; HRQL, health-related quality of life; LMICs, low-to-middle income countries; MCS, mental component summary; MOS SF-12, Medical Outcomes Study 12-item short-form general health survey; MOS, Medical Outcomes Study; PCS, physical component summary; PROs, patient-reported outcomes; SOF/LDV, sofosbuvir plus ledipasvir; SOF/RBV, sofosbuvir plus ribavirin; SVR, sustained virological response; W, week; WHO, World Health Organization; West Africa; direct-acting antivirals; health-related quality of life; hepatitis C; symptoms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article